No Data
Structure Therapeutics Announces Multiple Upcoming Presentations at ObesityWeek 2024
Top Small-cap Stock Picks From Morgan Stanley Following the Group's Upgrade to Neutral
BMO Capital Maintains Structure Therapeutics(GPCR.US) With Buy Rating, Maintains Target Price $100
Consumer, Labor Groups Urge FTC to Block Catalent Sale to Novo Nordisk - Report
10 Health Care Stocks With Whale Alerts In Today's Session
Does Structure Therapeutics Inc. Sponsored ADR (GPCR) Have the Potential to Rally 115.8% as Wall Street Analysts Expect?
No Data
No Data
